Synthesis, biological evaluation, and molecular docking studies of novel 3‐aryl‐5‐(alkyl‐thio)‐1H‐1,2,4‐triazoles derivatives targeting Mycobacterium tuberculosis
- 26 July 2017
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 90 (6) , 1206-1214
Abstract
A small library of new 3‐aryl‐5‐(alkyl‐thio)‐1H‐1,2,4‐triazoles was synthesized and screened for the antimycobacterial potency against Mycobacterium tuberculosis H37Ra strain and Mycobacterium bovis BCG both in active and dormant stage. Among the synthesized library, 25 compounds exhibited promising anti‐TB activity in the range of IC500.03–5.88 μg/ml for dormant stage and 20 compounds in the range of 0.03–6.96 μg/ml for active stage. Their lower toxicity (>100 μg/ml) and higher selectivity (SI = >10) against all cancer cell lines screened make them interesting compounds with potential antimycobacterial effects. Furthermore, to rationalize the observed biological activity data and to establish a structural basis for inhibition of M. tuberculosis, the molecular docking study was carried out against a potential target MTB CYP121 which revealed a significant correlation between the binding score and biological activity for these compounds. Cytotoxicity and in vivo pharmacokinetic studies suggested that 1,2,4‐triazole analogues have an acceptable safety index, in vivo stability and bio‐availability.Keywords
Funding Information
- Council for Scientific and Industrial Research
This publication has 34 references indexed in Scilit:
- Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure–Activity RelationshipsJournal of Medicinal Chemistry, 2013
- Bedaquiline: First FDA-approved tuberculosis drug in 40 yearsInternational Journal of Applied & Basic Medical Research, 2013
- Mycobacterium tuberculosis: success through dormancyFEMS Microbiology Reviews, 2012
- Synthesis and evaluation of antitumor activities of novel chiral 1,2,4-triazole Schiff bases bearing γ-butenolide moietyOrganic and Medicinal Chemistry Letters, 2012
- Activity of Drug Combinations against Dormant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2010
- Metronidazole plus Rifampin Sterilizes Long-Term Dormant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence?PLOS ONE, 2006
- Synthesis of Some New 4,5-Substituted-4H-1,2,4-triazole-3-thiol DerivativesMolecules, 2004
- Dormancy ofMycobacterium tuberculosis and latency of diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994